What should I know first?

Stimulant use disorder involves impaired control over stimulant use and significant consequences for health or everyday life. This article covers the clinical grouping that includes cocaine and amphetamine-type stimulants; tobacco and caffeine are classified separately. Cocaine, methamphetamine and prescribed stimulant medicines differ in their properties and medical uses.

Taking a prescribed ADHD medicine as directed does not by itself establish addiction. A useful assessment identifies the actual substance, pattern and consequences rather than attaching a diagnosis to anyone who has used a stimulant.

Signs and symptoms

Use may continue despite financial, relationship or health damage, with repeated failed attempts to stop. Daily use is not required for a problem to be serious. Sleep loss, appetite changes and a period of low mood or fatigue after use can add to the difficulty.

Clinical assessment

A clinical history identifies the actual substances, routes, pattern, medical symptoms and mental health needs. Assessment also considers prescribed medicines. Toxicology can add information but cannot decide whether symptoms are intoxication, withdrawal, a separate illness or more than one problem.

How Common Is It?

The burden differs substantially by substance, region and reporting period. Figures for any stimulant use should not be mistaken for the prevalence of stimulant use disorder, and cocaine and methamphetamine statistics cannot simply be merged without checking definitions. Treatment and overdose records also capture different aspects of harm.

Current professional guidance describes a serious public health problem, including complications from combined or unexpected opioid exposure. This article avoids a single universal percentage because populations, supply patterns and methods of identifying a disorder differ across studies.

What Causes It?

Risk involves the interaction of repeated exposure, individual vulnerability and circumstances. Stimulants may initially be used for energy, performance, pleasure or relief from distress; the experience can reinforce further use. Sleep loss and stress can make control more difficult. Mental health conditions, unstable living circumstances and limited access to treatment may complicate recovery, without making the disorder inevitable.

Prescribed treatment requires its own careful assessment rather than assumptions about addiction. Clinicians explore what maintains use and what practical changes could reduce harm and support lasting alternatives.

What Do We Know About the Brain?

Stimulants influence brain systems involved in alertness, reward and motivation. Repeated exposure can strengthen the pull of drug-related cues and disrupt sleep, mood and decision-making. When effects wear off, fatigue and reduced enjoyment can make returning to use tempting. These mechanisms help explain difficulties with control but do not define a person's character or determine their future.

Research findings are not a diagnostic brain test. Supporting sleep, physical health and meaningful everyday activities is part of recovery alongside interventions directed at substance use.

Conditions With Similar Symptoms

Mania, anxiety, ADHD, primary psychotic disorders and medical conditions can share features with stimulant intoxication or withdrawal. Sleep deprivation alone can worsen thinking and perception. The sequence of use and symptoms, previous episodes without substances and follow-up help distinguish these conditions.

A positive stimulant test does not exclude an independent disorder. Likewise, prescribed stimulant treatment is not automatically the explanation for new symptoms. Chest pain, seizures, severe agitation or delirium need immediate medical evaluation rather than being attributed only to a psychiatric diagnosis.

Other Conditions That Can Occur Together

Depression, anxiety, ADHD, trauma-related problems and other substance use disorders may coexist. Clinicians also assess cardiovascular complications and other physical health needs relevant to the person's exposure and circumstances. Opioid exposure may be intentional or unexpected, making overdose prevention important.

The presence of another disorder is not a reason to deny stimulant-use treatment. Plans should coordinate care, clarify which symptoms persist outside intoxication and provide appropriate support during periods of low mood or impaired judgement. Family or trusted supporters can contribute with the person's agreement.

Treatment in UK services

A GP or a direct approach to a local drug service can lead to a personalised plan and keyworker. NHS information describes talking therapies, selected couples work and incentive-based approaches; NICE CG51 supports contingency management for stimulant misuse.

Can medication help?

NHS information distinguishes stimulant care from opioid treatment: there is no equivalent established substitute medicine for cocaine, crack or other stimulants. A clinician may treat another condition or short-term symptoms. That is not the same as a licensed medicine that cures stimulant dependence.

What to Expect Over Time

Recovery is possible, but the pace varies. Sleep, energy, concentration and mood may need continuing attention after stopping or reducing use. Persistent symptoms should be assessed rather than assumed to be permanent brain damage or simply ignored as withdrawal. Return to use can indicate that the support plan needs adjustment.

Continued contact can help detect cardiovascular or psychiatric complications and maintain progress in everyday functioning. A clinician should reassess risk during transitions and periods of severe depression, not only when stimulant use is at its highest.

Practical and psychological support

Planning for high-risk situations and rebuilding ordinary activities can reduce the hold of drug-related cues. Peer support may complement treatment. Coexisting depression and anxiety deserve evidence-based help rather than being ignored until all substance use has stopped.

When to seek urgent help

Call local emergency services for chest pain, a seizure, collapse, severe confusion or overheating after stimulant use. New severe paranoia or immediate risk of self-harm also needs urgent assessment. These are safety symptoms, not evidence that a person is inherently violent or beyond help.

History and terminology

Stimulants have been used in medicine and outside care, with changing patterns of availability and harm. Older records may separate cocaine abuse and dependence or use amphetamine dependence. DSM-5 brought abuse and dependence into substance-use disorders while preserving distinctions between drug classes; ICD has its own related terminology.

Different stimulants, forms and patterns of exposure should not be collapsed into one stereotype. Their legitimate prescribed uses do not eliminate possible harms, but taking an ADHD medicine as directed is not by itself addiction.

Sources and References

  1. Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (2024)

    Scope: International scientific background; not UK prescribing or healthcare guidance.

  2. ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder

    Scope: International scientific background; not UK prescribing or healthcare guidance.

  3. What Is a Substance Use Disorder? (physician review 2024-04)

    Scope: International scientific background; not UK prescribing or healthcare guidance.

  4. Cocaine addiction: get help

    Scope: England service information.

  5. Cocaine

    Scope: Scotland public health information.

  6. Drug misuse in over 16s: psychosocial interventions — recommendations

    Scope: NICE guidance; national adoption and local implementation vary.

  7. Highlights of Changes from DSM-IV-TR to DSM-5 (2013)

    Scope: International explanatory background; not UK prescribing or service guidance.

  8. Opioid overdose

    Scope: International explanatory background; not UK prescribing or service guidance.

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top